Currently browsing tag

federal

More evidence for Zika virus link to damage beyond microcephaly

By Lisa Rapaport (Reuters Health) – The mosquito-borne Zika virus can lead to extensive birth defects that go beyond microcephaly, a Brazilian study suggests. Researchers studied 11 babies diagnosed with Zika and found they had a range of neurological impairments including small skulls and brains as well as an underdeveloped cerebellum, the part of the brain responsible for motor skills, and an absence of normal folds in the cerebral cortex, the gray matter that handles memory, language, social skills and problem solving. “Microcephaly is not the only thing that happens with fetal Zika infection,” said senior study author Dr. Amilcar Tanuri, a researcher in the laboratory of molecular virology at the Federal University of Rio de Janeiro.

U.S. prosecutors launch review of failed FedEx drug case

SAN FRANCISCO/WASHINGTON (Reuters) – The U.S. Department of Justice has begun a rare internal examination of what went wrong in the prosecution of a controversial drug conspiracy case against delivery service Federal Express , the department's top prosecutor in San Francisco told Reuters. The review plays into a broader debate about how the government prosecutes suspected corporate wrongdoing and could influence its approach to such cases in the future. Prosecutors obtained a grand jury indictment against FedEx in 2014 on charges the courier service had knowingly helped Internet pharmacies ship illegal pills.

FTC sues DeVry, alleging school deceived students about job prospects

The U.S. Federal Trade Commission filed a lawsuit against DeVry University, run by DeVry Education Group Inc, on Wednesday alleging the company deceived students about the prospect that they would find work. Share of DeVry were down 17.43 percent at $19.60 following the announcement of the FTC lawsuit around midday on Wednesday. The U.S. Department of Education, which has been cracking down on for-profit schools, said on Wednesday it had ordered DeVry to stop making certain claims about its graduates' employment.

Sanofi’s Genzyme pays $32.59 million in criminal Seprafilm case

The biotechnology unit of French drug company Sanofi SA was accused of two misdemeanor counts of violating the federal Food, Drug and Cosmetic Act from 2005 to 2010 by allowing Seprafilm to be adulterated and misbranded while being sold. Sanofi bought Genzyme in 2011. Seprafilm is a clear film used to reduce abnormal internal scarring that can cause organs and tissues to stick together following pelvic and abdominal surgeries known as laparotomies.